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Mn-SOD/ Cu, Zn-SODmRNAwas assessed by Reverse Transcription
(RT)-PCR/ Taqman real-time PCR (q-PCR).
Results: Infection with Ct was found in Group I (13.7%; n=
20/145) patients, viz.: SSA and RSA (11/85 and 9/60, respectively),
whereas none of controls were infected (Group II). Qualitatively,
bothMn-SOD (p < 0.0001) andCu, Zn-SOD (p < 0.05) showedupreg-
ulated expression in Group I (Ct-infected SSA/ RSA) versus Group
II (control) patients; however, level of Mn-SOD was signiﬁcantly
increased (p<0.0001) incomparison toCu, Zn-SOD.Similarﬁndings
were obtained by qPCR analysis as there was signiﬁcant differen-
tial expression of transcript level of SODs, viz.:Mn-SOD (p < 0.0001)
and Cu, Zn-SOD (p < 0.05) in infected SSA/ RSA patients (Group I).
Ct-infected RSA showed elevatedMn-SOD expression (p < 0.001) as
compared to infected SSA. However, no signiﬁcant difference was
found in expression of Cu, Zn-SOD between infected patients, viz.:
RSA versus SSA.
Conclusion: The study suggested that superoxide radical and
its scavenging system play important role in maintenance of preg-
nancy in Ct-infected women. Overall results indicated that both
SODs are differentially expressed and Mn-SOD plays greater pro-
tective role in Ct-associated early abortion.
http://dx.doi.org/10.1016/j.ijid.2016.02.467
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Background: Pregnant women infected with hepatitis B virus
(HBV) and HIV can transmit the infection to their fetuses and
newborns. The study was intended to determine co-infection of
hepatitis B and Human immunodeﬁciency virus and assessing risk
factors among ANC visiting women.
Methods & Materials: A hospital based cross-sectional study
was employed from July to October, 2014 in a total of 215 preg-
nant women. Enzyme Linked Immunosorbent Assay kit was used
to detect HBV seromarker and HIV antibody in serum. Descrip-
tive andmultivariate logistic regressionwas performed and P<0.05
considered as indicator of statistical signiﬁcance.
Results: The prevalence of hepatitis B infection in the study
area was 6%. High HBV positivity was recorded among the age
group 25 –29 years. Many risk factors for HBV acquisition exists
in study settings, but amongst these, history of abortion (AOR=19;
CI=2.78-130.367; P-value=0.003), surgery (AOR=9.8; CI=1.392-
69.610); P-value=0.0.022) and tattooing (AOR=7.7; CI=1.185-50.28;
P-value=0.033 were signiﬁcantly associated with HBV infection.
The prevalence of HIV infection was 4.19% and none of the
socio-demographic and the risk factors were associated with HIV
positivity.
Conclusion: The prevalence of hepatitis B among in the study
area was intermediate and the prevalence of HIV/HBV co-infection
was 2 (22.2%). This may warrant patterns toward high infectivity
and therefore maximized risk of perinatal infection transmission.
These capitalize the demand to step up preventive efforts against
both infection and perinatal transmission in our study set up and
the country.
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Background: Yellow fever vaccine (YFV) had been considered
the safest of the live virus vaccines. But, Yellow fever vaccine - asso-
ciated neurotropic disease (YEL - AND), previously called as post
- vaccinial encephalitis is a known rare adverse reaction to this
vaccine.
Methods & Materials: A 30 years old hypertensive male pre-
sented to us with high grade intermittent fever, severe headache
& multiple episodes of vomitting three days after receipt of a 17D
strain live attenuated yellow fever vaccine at a government hospi-
tal. Onexaminationhehadneck stiffnesswithpositiveKernig’s sign
without any focal neurological deﬁcit. Hewaspreviously diagnosed
as having chronic kidney disease 3 mnths ago & was on medical
follow up.
Results: Blood investigations showed anormal hemogram, liver
function tests and a borderline raised creatinine (1.8 mg/dL). Blood
investigations sent for the endemic tropical diseases like malaria,
dengue& leptospirosis cameout negative. Cerebrospinal ﬂuid (CSF)
was suggestive of viral meningitis (protein 101 mg/dL, sugar 50
mg/dL, total cells 82) with lymphocyte predominance. His CSF cul-
ture showed no growth. MRI Brain was normal. He was treated
symptomatically. His symptoms resolved over next 2-3 days & he
was discharged without any focal neurological deﬁcit. We believe
that he suffered a rare complication of yellow fever vaccine - YEL-
AND since no other cause was found.
Conclusion: The two important complications of YFV are YEL-
AND & Yellow fever vaccine associated viscerotropic disease (YEL
– AVD).
The incidence of YEL - AND in United States is 0.8 per 1,00,000
doses administered. It represents a conglomerate of clinical syn-
dromes, including meningoencephalitis, Guillain-Barré syndrome,
acute disseminated encephalomyelitis, and rarely, cranial nerve
palsies. The onset of illness for documented cases is 3–28 days after
vaccination. It is rarely fatal & is treated symptomatically.
http://dx.doi.org/10.1016/j.ijid.2016.02.469
